Analytic Validation of a Next Generation Sequencing Based Primary Immunodeficiency Panel
Apr 24, 2018
Genetics diagnostics of patients with suspicion of immunodeficiency has been affected by poorly validated genetic tests, lack of transparency, and testing solutions that are not optimized for maximal diagnostic yield. Our goal was to develop a high quality next generation sequencing (NGS) platform, transparently and comprehensively validate its quality and performance, and report our experiences with hundreds of patients suspected with primary immunodeficiency (PID).
Note: due to a temporary technical limitation the newsletter subscription form below does not load in some browsers if cookies have not been allowed. If you do not see the form below, please allow cookies by clicking here to open the cookie preference centre, then allow cookies and reload this page. You can disallow cookies once you have signed up if you wish.
Please be advised that we only accept specimen collection kit requests from medical professionals.
If you are a patient or family member of a patient, please contact your provider to place a kit order on your behalf. You can order up to 10 kits per type and 30 kits total. If you need more kits, please contact our customer support team.